Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Todd Neale

October 30, 2024

Presentation NY Valves 2024

Percutaneous PVR II: What Technologies Are Coming, and How Will They Change Things?

Presenter: Barry A. Love

June 07, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

Presentation TVT 2022

Exercise PVR, A Key Predictor of Benefit of Atrial Shunt Therapy in HFpEF?

Presenter: Sanjiv Shah

June 10, 2022

News Daily News

Tailored TAVI: Standardizing Balloon Pressures May Curb Operator Angst

L.A. McKeown

October 28, 2021

News Conference News TVT 2020

Newer TAVR Devices Reassure in Failed Surgical Valves

Shelley Wood

June 20, 2020

Presentation CACI 2019

Transcatheter pulmonary valve replacement: how to select patients & valves?

Presenter: Alejandro Peirone

November 29, 2019

News Conference News AHA 2019

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

Yael L. Maxwell

November 18, 2019

News Daily News

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

Shelley Wood

October 08, 2019

News Conference News TCT 2019

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

Todd Neale

September 29, 2019

Presentation TCT 2019

Extreme Aortic Valve Complex Calcification Creating High Risk for TAVR Complications (Rupture or PVR): Case Presentation and Procedural Decision-Making

Presenter: Chiu Wong

September 27, 2019

News Daily News

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Michael O'Riordan

September 27, 2017

Presentation

Association of PVR With 1-Year Outcomes After TAVR With Sapien 3 Valve

September 27, 2017

Presentation TCT 2016

Complications of Transcatheter PVR

Presenter: John P. Cheatham, Matthew J. Gillespie, Thomas K. Jones

November 01, 2016

Presentation TCT 2016

Transcatheter PVR for Native Outflow Tracts: How Much Can We Do With the Currently Approved Valves (Including Hybrid)?

Presenter: John P. Cheatham, Matthew J. Gillespie, Evan Zahn

November 01, 2016

Presentation TCT 2016

Transcatheter PVR Using the Edwards and Melody Valves in Patients With Conduits and Bioprosthetic Valves: Technical Considerations

Presenter: John P. Cheatham, Matthew J. Gillespie, Jacqueline Kreutzer

November 01, 2016

Presentation TCT 2016

Assessment of PR Severity, and Review of the Guidelines for Transcatheter PVR

Presenter: John P. Cheatham, Matthew J. Gillespie

November 01, 2016

Advertisement

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Percutaneous PVR II: What Technologies Are Coming, and How Will They Change Things?

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Exercise PVR, A Key Predictor of Benefit of Atrial Shunt Therapy in HFpEF?

Tailored TAVI: Standardizing Balloon Pressures May Curb Operator Angst

Newer TAVR Devices Reassure in Failed Surgical Valves

Transcatheter pulmonary valve replacement: how to select patients & valves?

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

Extreme Aortic Valve Complex Calcification Creating High Risk for TAVR Complications (Rupture or PVR): Case Presentation and Procedural Decision-Making

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Association of PVR With 1-Year Outcomes After TAVR With Sapien 3 Valve

Complications of Transcatheter PVR

Transcatheter PVR for Native Outflow Tracts: How Much Can We Do With the Currently Approved Valves (Including Hybrid)?

Transcatheter PVR Using the Edwards and Melody Valves in Patients With Conduits and Bioprosthetic Valves: Technical Considerations

Assessment of PR Severity, and Review of the Guidelines for Transcatheter PVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content